Skip to content
value.today
Total raised
$413 M
7 rounds on record
Latest round
$195 M
May 2015
First round on record
Dec 2009
Today
Went public
See the company page

Adaptive TCR Corp is listed today as Adaptive Biotechnologies Corporation: market value, financials and filings are on its company page.

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Adaptive TCR Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2015$195 MNo. 7$50 to $250 million

Adaptive TCR Corp: Raise no. 7, May 2015

Investors in this round

16 investors had bought by the notice of May 11, 2015: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$195 M of $195 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Dean Schorno · Executive Officer
  • Kathleen Determann · Executive Officer
  • Andris Zoltners · Director
  • Arnold Levine · Director
  • Chad Cohen · Director
  • John Stuelpnagel · Director
  • Peter Neupert · Director
  • Rob Hershberg · Director
  • Rob Rosen · Director
  • Tom Willis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chad Robins, President and CEO. Source: SEC Form D, newest notice filed May 11, 2015. Read the notice at the SEC.

equitySEC
Jan 2015$94 MNo. 6$50 to $250 million

Adaptive TCR Corp: Raise no. 6, Jan 2015

Investors in this round

4 investors had bought by the notice of Jan 22, 2015: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$94 M of $94 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Dean Schorno · Executive Officer
  • Kathleen Determann · Executive Officer
  • Andris Zoltners · Director
  • Arnold Levine · Director
  • John Stuelpnagel · Director
  • Lee Huntsman · Director
  • Peter Neupert · Director
  • Rob Hershberg · Director
  • Rob Rosen · Director
  • Tom Willis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chad Robins, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jan 22, 2015. Read the notice at the SEC.

equitySEC
Apr 2014$107 MNo. 5$50 to $250 million

Adaptive TCR Corp: Raise no. 5, Apr 2014

Investors in this round

6 investors had bought by the notice of Aug 4, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$107 M of $107 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Chris Carlson · Executive Officer
  • Harlan Robins · Executive Officer
  • Andris Zoltners · Director
  • Arnold Levine · Director
  • Lee Huntsman · Director
  • Peter Neupert · Director
  • Rob Hershberg · Director
  • Rob Rosen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chad Robins, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Aug 4, 2014. Read the notice at the SEC.

equitySEC
Jul 2013$5 MNo. 4$2 to $10 million

Adaptive TCR Corp: Raise no. 4, Jul 2013

Investors in this round

3 investors had bought by the notice of Jul 12, 2013: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $20 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Chris Carlson · Executive Officer
  • Harlan Robins · Executive Officer
  • Andris Zoltners · Director
  • Arnold Levine · Director
  • Lee Huntsman · Director
  • Rob Hershberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chad Robins, President and CEO. Source: SEC Form D, newest notice filed Jul 12, 2013. Read the notice at the SEC.

equitySEC
Jun 2012$3 MNo. 3$2 to $10 million

Adaptive TCR Corp: Raise no. 3, Jun 2012

Investors in this round

37 investors had bought by the notice of Jun 21, 2012: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Chris Carlson · Executive Officer
  • Harlan Robins · Executive Officer
  • Andy Zoltners · Director
  • Arnold Levine · Director
  • Craig Weissman · Director
  • Lee Huntsman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chad Robins, President and CEO. Source: SEC Form D, newest notice filed Jun 21, 2012. Read the notice at the SEC.

equitySEC
May 2011$6 MNo. 2$2 to $10 million

Adaptive TCR Corp: Raise no. 2, May 2011

Investors in this round

63 investors had bought by the notice of Jun 2, 2011: 63 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Chris Carlson · Executive Officer
  • Harlan Robins · Executive Officer
  • Andy Zoltners · Director
  • Craig Weissman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chad Robins, President and CEO. Source: SEC Form D, newest notice filed Jun 2, 2011. Read the notice at the SEC.

equitySEC
Dec 2009$4 MNo. 1$2 to $10 million

Adaptive TCR Corp: Raise no. 1, Dec 2009

Investors in this round

50 investors had bought by the notice of Dec 28, 2009: 50 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Adaptive TCR Corp as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$300,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Washington

People named in the notice

  • Chad Robins · Executive Officer, Director
  • Chris Carlson · Executive Officer
  • Harlan Robins · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds may be used to pay ordinary salaries of executive officers.”

Signed by Chad Robins, President and CEO. Source: SEC Form D, newest notice filed Dec 28, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Adaptive Biotechnologies Corporation, its revenue in fiscal 2025 came from these product and service lines: Immune Medicine Service Revenue $41.30 million (15%).

    Annual report (SEC XBRL) · Dec 2025

  • Adaptive TCR Corp chose not to state its revenue in its newest notice of a funding round (May 2015).

    SEC Form D · May 2015

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2015

Products and services#

No products or services of Adaptive TCR Corp are on record.

Investors#

15 named in official filings. Open an investor to see everything it has backed.

Investors in Adaptive TCR Corp
InvestorKindAmountRoundRoleSource
Andris A. ZoltnersPersonnot statednot statedHeld Series A, B, C, E-1 and F preferred stock, director (Form 3, 2019)SEC Form 3
Chad M. RobinsPersonnot statednot statedHeld Series E-1 preferred stock, director (Form 3, 2019)SEC Form 3
Harlan S. RobinsPersonnot statednot statedHeld Series E-1 preferred stock (Form 3, 2019)SEC Form 3
Matrix Capital Management Company, LPFund or asset managernot statednot statedHeld Series A, E-1, F and F-1 preferred (Form 3, 2019)SEC Form 3
VGE III Portfolio Ltd.Companynot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Equities II LPFund or asset managernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Equities LPFund or asset managernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Equities Master Ltd.Companynot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Investors LPFund or asset managernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Opportunities GP LLCOthernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Opportunities Illiquid Investments Sub-Master LPFund or asset managernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Opportunities Portfolio GP LLCOthernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Global Performance LLCOthernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Long Fund GP LLCFund or asset managernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3
Viking Long Fund Master Ltd.Fund or asset managernot statednot statedHeld Series D, E, F and F-1 preferred stock, 10% owner (Form 3, 2019)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 63 investors.

Largest shareholders today

Institutions holding Adaptive Biotechnologies Corporation shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Adaptive TCR Corp
NameRoleNamed in
Chad RobinsExecutive officerMay 2015
Dean SchornoExecutive officerMay 2015
Kathleen DetermannExecutive officerMay 2015
Chris CarlsonExecutive officerAug 2014
Harlan RobinsExecutive officerAug 2014
Andris ZoltnersDirectorMay 2015
Arnold LevineDirectorMay 2015
Chad CohenDirectorMay 2015
Chad RobinsDirectorMay 2015
John StuelpnagelDirectorMay 2015
Peter NeupertDirectorMay 2015
Rob HershbergDirectorMay 2015
Rob RosenDirectorMay 2015
Tom WillisDirectorMay 2015
Lee HuntsmanDirectorJan 2015
Andy ZoltnersDirectorJun 2012
Craig WeissmanDirectorJun 2012
Harlan RobinsDirectorDec 2009

About

Company in Seattle, United States.

Went public since 2019. Its SEC number is that of a company listed on a stock exchange.